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Novel Aspect: This is the first metabolomics standard reference material from a national 
metrology institute. 
 
Introduction: Metabolomics attempts to understand biological function or disease through 
broad surveys of metabolites in relevant samples.  Experiments are either identification 
based or quantification based; or a combination of both approaches is used.  Standard 
reference materials (SRMs) establish traceability to a common sample, thus 
benchmarking the analytical method and/or improving the quantitative accuracy by 
providing a point of reference for calibration procedures.  The intended use for NIST 
SRM 1950 is the evaluation of qualitative and quantitative analytical methods for 
metabolites in human plasma.  The concentrations of approximately 40 metabolites were 
determined; most with isotope-dilution mass spectrometry.  An additional approximately 
250 metabolites were identified in the plasma using GC/MS and LC/MS instrumentation 
and mass spectral library searching.   
  
Methods:  SRM 1950 is a human plasma pool designed to represent a normal 
metabolome.  It was obtained from an equal number of men and women in a narrow age 
range, with a racial distribution similar to that of the U.S. population.  Contributing 
individuals should not have taken medication prior to the blood draw and were free from 
overt diseases, and disorders.  The approximately 40 metabolites were quantified using 
established definitive methods developed at NIST.  Metabolite identification was 
performed primarily using 2 instruments: GCxGC/TOF and LC/ion trap MS, with 
GC/quadrupole MS, LC/Q-TOF and NMR used to verify identifications.  The data was 
managed using a custom database and the R statistical programming language.  The 
metabolites were classified according the uncertainty in their identifications. 
 
Preliminary Data: The metabolites were quantified using several methods, each 
optimized specifically for a group of closely related target analytes.  Fatty acids, glucose, 
and cholesterol were quantified using isotope-dilution GC/MS methods.  Testosterone, 
cortisol, progesterone, folates, homocysteine, creatinine, and amino acids were quantified 
using isotope-dilution LC/MS/MS methods.  Carotenoids, retinol, and tocopherols 
measured by LC-UV.  Total protein was determined using UV-VIS spectrophotometry. 
The concentration of the metabolites in SRM 1950 ranged from approximately 0.001 
pmol/µL to 10000 pmol/ µL.  The approximately 250 identified metabolites were amino 
acids, organic acids including fatty acids, sugars, pharmaceuticals (contrary to the plasma 
pool requirements) and other miscellaneous compounds.  Metabolites were identified by 
searching the NIST electron impact or MS/MS mass spectral libraries.  In some cases, 
authentic reference compounds were used for verification.  The ability of the different 
mass spectrometers to identify various types of metabolites was compared.  To meet 
reporting guidelines and assist with the evaluation of qualitative methods, NIST will 
make the information it used to identify the metabolites publically available.  This 
includes, for both the identified metabolites and the authentic reference compounds, a 
detailed description of the methods, retention times/retention indices, tandem mass 
spectra, electron impact mass spectra, and total ion chromatograms obtained on various 
chromatographic stationary phases.  If the user’s quantitative method is for a 
metabolite(s) with a certified concentration in SRM 1950, the SRM can be used to assess 
the method’s accuracy with traceability to NIST.  SRM 1950 can also be used to evaluate 
profiling or identification methods by benchmarking the ability of the method to identify 
specific metabolites or a certain number of metabolites in plasma.  This metric can be 
tracked over time to check method repeatability, or as the method is intentionally 
changed. 
